BMRN Historical Earnings image   This BMRN historical earnings page last updated 1/26/2023
BMRN Historical Revenue
PeriodHistorical Earnings DateGAAP
Q3 202210/26/20220.51B
Q2 20228/3/20220.53B
Q1 20224/27/20220.52B
Q4 20212/23/20220.45B
Q3 202110/27/20210.41B
Q2 20217/28/20210.50B
Q1 20214/29/20210.49B
Q4 20202/25/20210.45B
Q3 202011/5/20200.48B
Q2 20208/4/20200.43B
Q1 20204/29/20200.50B
Q4 20192/26/20200.45B
Q3 201910/23/20190.46B
Q2 20198/1/20190.39B
Q1 20194/25/20190.40B
Q4 20182/21/2019353.21M
Q3 201810/25/2018391.71M
Q2 20188/2/2018372.85M
Q1 20184/25/2018373.45M
Q4 20172/22/2018358.31M
Q3 201710/26/2017334.15M
Q2 20178/2/2017317.45M
Q1 20175/4/2017303.75M
Q4 20162/23/2017300.09M
Q3 201610/27/2016279.90M
Q2 20168/4/2016300.13M
Q1 20164/28/2016236.74M
Q4 20152/25/2016227.94M
Q3 201510/29/2015208.90M
Q2 20158/3/2015250.52M
Q1 20154/30/2015203.26M
Q4 20142/25/2015230.90M
Q3 201410/23/2014176.80M
Q2 20147/30/2014191.80M
Q1 20145/1/2014151.60M
Q4 20132/26/2014146.90M
Q3 201310/24/2013136.87M
Q2 20137/25/2013136.81M
Q1 20134/25/2013127.90M
Q4 20122/21/2013131.94M
Q3 201210/25/2012128.12M
Q2 20128/1/2012124.00M
Q1 20123/31/2012116.65M
BMRN Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q3 202210/26/2022-0.040
Q2 20228/3/20220.590
Q1 20224/27/20220.170
Q4 20212/23/2022-0.320
Q3 202110/27/2021-0.200
Q2 20217/28/20210.070
Q1 20214/29/20210.090
Q4 20202/25/20210.120
Q3 202011/5/20204.010
Q2 20208/4/2020-0.160
Q1 20204/29/20200.440
Q4 20192/26/20200.080
Q3 201910/23/20190.300
Q2 20198/1/2019-0.290
Q1 20194/25/2019-0.320
Q4 20182/21/2019-0.03
Q3 201810/25/2018-0.07
Q2 20188/2/2018-0.09
Q1 20184/25/2018-0.26
Q4 20172/22/20180.03
Q3 201710/26/2017-0.07
Q2 20178/2/2017-0.21
Q1 20175/4/2017-0.09
Q4 20162/23/2017-0.53
Q3 201610/27/2016-0.26
Q2 20168/4/2016-2.61
Q1 20164/28/2016-0.17
Q4 20152/25/20160.39
Q3 201510/29/2015-0.57
Q2 20158/3/2015-0.51
Q1 20154/30/2015-0.16
Q4 20142/25/2015-0.47
Q3 201410/23/20140.5
Q2 20147/30/2014-0.23
Q1 20145/1/2014-0.01
Q4 20132/26/2014-0.44
Q3 201310/24/2013-0.38
Q2 20137/25/2013-0.16
Q1 20134/25/2013-0.31
Q4 20122/21/2013-0.43
Q3 201210/25/2012-0.04
Q2 20128/1/2012-0.27
Q1 20123/31/2012-0.21
Quotes delayed 20 minutes

Email EnvelopeFree BMRN Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Biomarin Pharmaceutical (BMRN) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

BMY Historical Earnings
BNGO Historical Earnings
BOLT Historical Earnings
BPMC Historical Earnings
BPTH Historical Earnings
BRKR Historical Earnings
BRTX Historical Earnings
BSGM Historical Earnings
BSX Historical Earnings
BTAI Historical Earnings
What was the record high BMRN historical earnings result?
In terms of earnings or revenue, what is the best BMRN historical earnings result that Biomarin Pharmaceutical has ever posted, and when?

✔️Accepted answer: Within our data set, the highest BMRN historical earnings result was set in Q3 2020, when Biomarin Pharmaceutical posted results of 4.010/share. The most successful revenue quarter within our data set was Q2 2022 when Biomarin Pharmaceutical reported revenue of 0.53B.

What was the lowest Biomarin Pharmaceutical historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest BMRN has reported, and when?

✔️Accepted answer: Within our data set, the lowest BMRN historical earnings result was set in Q2 2016, when Biomarin Pharmaceutical posted results of -2.61/share. The smallest revenue quarter within our data set was Q1 2012 when Biomarin Pharmaceutical reported revenue of 116.65M.

On this page we presented the BMRN historical earnings date information for Biomarin Pharmaceutical. Reviewing that BMRN Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q3 2020, when BMRN posted gaap of 4.010/share. Meanwhile the lowest BMRN historical earnings result was in Q2 2016, when BMRN posted gaap of -2.61/share. Moving to Biomarin Pharmaceuticals historical revenue numbers, the largest revenue quarter in our data set was seen in Q2 2022 when BMRN reported 0.53B in revenue, while the smallest revenue quarter was Q1 2012 when BMRN reported 116.65M in revenue.

For self directed investors doing their due diligence on BMRN or any other given stock, their research can benefit from looking into all of the Biomarin Pharmaceutical historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you to make it more convenient for investors to look into Biomarin Pharmaceutical historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for BMRN. Thanks for visiting, and the next time you need to research BMRN historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: Top Ten Hedge Funds Holding ICL, BYSI YTD Return, Top Ten Hedge Funds Holding TI.


BMRN Historical Earnings | | Copyright © 2020 - 2023, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.